1
|
Noé E, Gómez A, Bernabeu M, Quemada I, Rodríguez R, Pérez T, López C, Laxe S, Colomer C, Ríos M, Juárez-Belaúnde A, González C, Pelayo R, Ferri J. Guidelines: basic principles of neurorehabilitation for patients with acquired brain injury. Recommendations of the Spanish Society of Neurorehabilitation. Neurologia 2024; 39:261-281. [PMID: 37116696 DOI: 10.1016/j.nrleng.2023.04.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2021] [Accepted: 06/27/2021] [Indexed: 04/30/2023] Open
Abstract
INTRODUCTION We present the Spanish Society of Neurorehabilitation's guidelines for adult acquired brain injury (ABI) rehabilitation. These recommendations are based on a review of international clinical practice guidelines published between 2013 and 2020. DEVELOPMENT We establish recommendations based on the levels of evidence of the studies reviewed and expert consensus on population characteristics and the specific aspects of the intervention or procedure under research. CONCLUSIONS All patients with ABI should receive neurorehabilitation therapy once they present a minimal level of clinical stability. Neurorehabilitation should offer as much treatment as possible in terms of frequency, duration, and intensity (at least 45-60minutes of each specific form of therapy that is needed). Neurorehabilitation requires a coordinated, multidisciplinary team with the knowledge, experience, and skills needed to work in collaboration both with patients and with their families. Inpatient rehabilitation interventions are recommended for patients with more severe deficits and those in the acute phase, with outpatient treatment to be offered as soon as the patient's clinical situation allows it, as long as intensity criteria can be maintained. The duration of treatment should be based on treatment response and the possibilities for further improvement, according to the best available evidence. At discharge, patients should be offered health promotion, physical activity, support, and follow-up services to ensure that the benefits achieved are maintained, to detect possible complications, and to assess possible changes in functional status that may lead the patient to need other treatment programmes.
Collapse
Affiliation(s)
- E Noé
- NEURORHB Servicio de Neurorrehabilitación de Hospitales Vithas, Fundación Hospitales Vithas, Valencia, Spain.
| | - A Gómez
- Centro Estatal de Atención al Daño Cerebral-CEADAC, Madrid, Spain
| | | | - I Quemada
- Red Menni de Daño Cerebral, Bilbao, Spain
| | | | - T Pérez
- Clínica San Vicente, Madrid, Spain
| | - C López
- Centro Lescer, Madrid, Spain
| | - S Laxe
- Hospital Clínic, Barcelona, Spain
| | - C Colomer
- NEURORHB Servicio de Neurorrehabilitación de Hospitales Vithas, Fundación Hospitales Vithas, Valencia, Spain
| | - M Ríos
- Unidad de Daño Cerebral, Hospital Beata María Ana, Madrid, Spain
| | | | - C González
- Centro Estatal de Atención al Daño Cerebral-CEADAC, Madrid, Spain
| | - R Pelayo
- Institut Guttmann, Barcelona, Spain
| | - J Ferri
- NEURORHB Servicio de Neurorrehabilitación de Hospitales Vithas, Fundación Hospitales Vithas, Valencia, Spain
| |
Collapse
|
2
|
Ruano-Zaragoza M, Torrent-Rodríguez A, Araujo-Sanchez G, Ribó P, Loli-Ausejo D, Solis K, Sánchez-Fernández MC, Bolaños J, Bolós U, López C, Ruiz S, Pascal M, Bartra J, Muñoz-Cano R. Successful Oral Dasatinib Desensitization in Immediate Hypersensitivity. J Investig Allergol Clin Immunol 2023; 34:0. [PMID: 38131221 DOI: 10.18176/jiaci.0985] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2023] Open
Affiliation(s)
- M Ruano-Zaragoza
- Allergy Department, Hospital Clinic, Barcelona, Spain
- Clinical & Experimental Respiratory Immunoallergy, Institut Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain
- RETIC Asma, Reacciones Adversas y Alergia (ARADyAL) and RICORS Red de Enfermedades Inflamatorias (REI), Madrid, Spain
| | | | - G Araujo-Sanchez
- Allergy Department, Hospital Clinic, Barcelona, Spain
- Clinical & Experimental Respiratory Immunoallergy, Institut Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain
- RETIC Asma, Reacciones Adversas y Alergia (ARADyAL) and RICORS Red de Enfermedades Inflamatorias (REI), Madrid, Spain
| | - P Ribó
- Allergy Department, Hospital Clinic, Barcelona, Spain
| | - D Loli-Ausejo
- Allergy Department, Hospital Clinic, Barcelona, Spain
| | - K Solis
- Allergy Department, Hospital Clinic, Barcelona, Spain
| | | | - J Bolaños
- Immunology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain
| | - U Bolós
- Immunology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain
| | | | | | - M Pascal
- RETIC Asma, Reacciones Adversas y Alergia (ARADyAL) and RICORS Red de Enfermedades Inflamatorias (REI), Madrid, Spain
- Immunology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain
| | - J Bartra
- Allergy Department, Hospital Clinic, Barcelona, Spain
- Clinical & Experimental Respiratory Immunoallergy, Institut Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain
- RETIC Asma, Reacciones Adversas y Alergia (ARADyAL) and RICORS Red de Enfermedades Inflamatorias (REI), Madrid, Spain
| | - R Muñoz-Cano
- Allergy Department, Hospital Clinic, Barcelona, Spain
- Clinical & Experimental Respiratory Immunoallergy, Institut Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain
- RETIC Asma, Reacciones Adversas y Alergia (ARADyAL) and RICORS Red de Enfermedades Inflamatorias (REI), Madrid, Spain
| |
Collapse
|
3
|
Remesar S, Matute R, Díaz P, Martínez-Calabuig N, Prieto A, Díaz-Cao JM, López-Lorenzo G, Fernández G, López C, Panadero R, Díez-Baños P, Morrondo P, García-Dios D. Tick-borne pathogens in ticks from urban and suburban areas of north-western Spain: Importance of Ixodes frontalis harbouring zoonotic pathogens. Med Vet Entomol 2023; 37:499-510. [PMID: 36896712 DOI: 10.1111/mve.12648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/14/2022] [Accepted: 02/26/2023] [Indexed: 06/18/2023]
Abstract
To identify the questing tick populations in urban and suburban areas from the city of Lugo (NW Spain), ticks were collected monthly by flagging. The presence of Borrelia spp., Rickettsia spp. and Anaplasma phagocytophilum also was determined by polymerase chain reaction (PCR) and sequence analysis. Overall, 342 questing ticks were collected; the tick abundance was higher in suburban (95.9%) than in urban areas (4.1%). Ixodes frontalis was the most abundant (86.5%); 88.5% were larvae, 11.1% nymphs and 0.3% adults. All development stages of I. ricinus (7.3%) and adults of Rhipicephalus sanguineus sensu lato (5.8%) and Dermacentor reticulatus (0.3%) were found. Rickettsia spp. (31.9%) was more prevalent than Borrelia spp. (2.7%); no ticks were positive to A. phagocytophilum. Six Rickettsia species were identified (R. slovaca, R. monacensis, R. massiliae, R. raoultii, R. sibirica subsp. mongolitimonae and R. aeschielmanii); Candidatus Rickettsia rioja and two novel Rickettsia species also were detected. In addition, Borrelia turdi (1.8%) and B. valaisiana (0.9%) were identified in Ixodes ticks. This is the first report of R. slovaca in R. sanguineus s.l. and of R. monacensis, R. raoultii, R. slovaca, R. sibirica subsp. mongolitimonae and Ca. R. rioja in I. frontalis. Since most of the pathogens detected are zoonotic, their presence in these areas may have implications for public health.
Collapse
Affiliation(s)
- S Remesar
- Investigación en Sanidad Animal: Galicia (Grupo INVESAGA), Facultade de Veterinaria, Universidade de Santiago de Compostela, Lugo, Spain
| | - R Matute
- Investigación en Sanidad Animal: Galicia (Grupo INVESAGA), Facultade de Veterinaria, Universidade de Santiago de Compostela, Lugo, Spain
| | - P Díaz
- Investigación en Sanidad Animal: Galicia (Grupo INVESAGA), Facultade de Veterinaria, Universidade de Santiago de Compostela, Lugo, Spain
| | - N Martínez-Calabuig
- Investigación en Sanidad Animal: Galicia (Grupo INVESAGA), Facultade de Veterinaria, Universidade de Santiago de Compostela, Lugo, Spain
| | - A Prieto
- Investigación en Sanidad Animal: Galicia (Grupo INVESAGA), Facultade de Veterinaria, Universidade de Santiago de Compostela, Lugo, Spain
| | - J M Díaz-Cao
- Investigación en Sanidad Animal: Galicia (Grupo INVESAGA), Facultade de Veterinaria, Universidade de Santiago de Compostela, Lugo, Spain
| | - G López-Lorenzo
- Investigación en Sanidad Animal: Galicia (Grupo INVESAGA), Facultade de Veterinaria, Universidade de Santiago de Compostela, Lugo, Spain
| | - G Fernández
- Investigación en Sanidad Animal: Galicia (Grupo INVESAGA), Facultade de Veterinaria, Universidade de Santiago de Compostela, Lugo, Spain
| | - C López
- Investigación en Sanidad Animal: Galicia (Grupo INVESAGA), Facultade de Veterinaria, Universidade de Santiago de Compostela, Lugo, Spain
| | - R Panadero
- Investigación en Sanidad Animal: Galicia (Grupo INVESAGA), Facultade de Veterinaria, Universidade de Santiago de Compostela, Lugo, Spain
| | - P Díez-Baños
- Investigación en Sanidad Animal: Galicia (Grupo INVESAGA), Facultade de Veterinaria, Universidade de Santiago de Compostela, Lugo, Spain
| | - P Morrondo
- Investigación en Sanidad Animal: Galicia (Grupo INVESAGA), Facultade de Veterinaria, Universidade de Santiago de Compostela, Lugo, Spain
| | - D García-Dios
- Investigación en Sanidad Animal: Galicia (Grupo INVESAGA), Facultade de Veterinaria, Universidade de Santiago de Compostela, Lugo, Spain
| |
Collapse
|
4
|
Remesar S, Méndez A, Benito A, Prieto A, García-Dios D, López C, Panadero R, Díez-Baños P, Morrondo P, Díaz P. A novel time-saving multiplex PCR assay for detecting and discriminating the most common canine Babesia species in Europe. Res Vet Sci 2023; 158:235-239. [PMID: 37037145 DOI: 10.1016/j.rvsc.2023.04.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2023] [Revised: 03/31/2023] [Accepted: 04/02/2023] [Indexed: 04/08/2023]
Abstract
In Europe, most cases of canine babesiosis are caused by Babesia canis, Babesia vogeli (large piroplasms) and Babesia vulpes (small piroplasm). Molecular diagnosis is recommended due to its high sensitivity. Species identification after sequencing allows applying a rapid and efficient treatment, leading to a better prognosis; however, it is expensive and time-consuming. Thus, the objective of the present study was to develop a time-saving multiplex polymerase chain reaction (PCR) for simultaneously detecting and discriminating between large and small forms without sequence analysis. A new multiplex PCR was designed and tested using blood samples from 79 dogs showing clinical signs compatible with babesiosis which were previously analysed using blood smears and molecular methods. Multiplex PCR successfully discriminated between both Babesia groups showing bands of 700 and 890 bp for B. canis/B. vogeli and B. vulpes, respectively. No significant differences in the results of both PCR were detected and a substantial agreement between protocols (κ = 0.64) was found. Our multiplex PCR represents a reliable tool for detecting infections by the major Babesia spp. in dogs from Europe. Since no sequence analysis is required for identifying the species involved, this PCR allows the rapid administration of an appropriate treatment, thus improving the survival rate of the infected animals. In addition, it will represent a helpful tool for unravelling the real prevalence and distribution of B. vulpes and its implication in clinical cases.
Collapse
|
5
|
Díaz-Fernández F, Celma A, Salazar A, Moreno O, López C, Cuadras M, Regis L, Planas J, Morote J, Trilla E. Systematic review of methods used to improve the efficacy of magnetic resonance in early detection of clinically significant prostate cancer. Actas Urol Esp 2023; 47:127-139. [PMID: 36462603 DOI: 10.1016/j.acuroe.2022.11.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2021] [Accepted: 04/28/2022] [Indexed: 12/02/2022]
Abstract
BACKGROUND AND OBJECTIVE Prostate cancer (PC) is the malignant neoplasm with the highest incidence after lung cancer worldwide. The objective of this study is to review the literature on the methods that improve the efficacy of the current strategy for the early diagnosis of clinically significant PC (csPC), based on the performance of magnetic resonance imaging (RM) and targeted biopsies when suspicious lesions are detected, in addition to systematic biopsy. EVIDENCE ACQUISITION A systematic literature review was performed in PubMed, Web of Science and Cochrane according to the PRISMA criteria (Preferred Reporting Items for Systematic Reviews and Meta-Analyses), using the search terms: multiparametric magnetic resonance imaging, biparametric magnetic resonance imaging, biomarkers in prostate cancer, prostate cancer y early diagnosis. A total of 297 references were identified and, using the PICO selection criteria, 21 publications were finally selected to synthesize the evidence. EVIDENCE SYNTHESIS With the consolidation of MRI as the test of choice for the diagnosis of prostate cancer, the role of PSA density (PSAD) becomes relevant as a predictive tool included in prediction nomograms, without added cost. PSAD and diagnostic markers, combined with MRI, offer a high diagnostic power with an area under curve (AUC) above 0.7. Only the SHTLM3 model integrates markers in the creation of a nomogram. Prediction models also offer consistent efficacy with an AUC greater than 0.8 when associating MRI. CONCLUSIONS The efficacy of MRI in clinically significant prostate cancer detection can be improved with different parameters in order to generate predictive models that support decision making.
Collapse
Affiliation(s)
- F Díaz-Fernández
- Departamento de Urología y Trasplante Renal, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
| | - A Celma
- Departamento de Urología y Trasplante Renal, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - A Salazar
- Departamento de Urología y Trasplante Renal, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - O Moreno
- Departamento de Urología y Trasplante Renal, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - C López
- Departamento de Urología y Trasplante Renal, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - M Cuadras
- Departamento de Urología y Trasplante Renal, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - L Regis
- Departamento de Urología y Trasplante Renal, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - J Planas
- Departamento de Urología y Trasplante Renal, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - J Morote
- Departamento de Urología y Trasplante Renal, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Universistat Autònoma de Barcelona, Barcelona, Spain
| | - E Trilla
- Departamento de Urología y Trasplante Renal, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Universistat Autònoma de Barcelona, Barcelona, Spain
| |
Collapse
|
6
|
Rache L, Blondin L, Diaz Tatis P, Flores C, Camargo A, Kante M, Wonni I, López C, Szurek B, Dupas S, Pruvost O, Koebnik R, Restrepo S, Bernal A, Vernière C. A minisatellite-based MLVA for deciphering the global epidemiology of the bacterial cassava pathogen Xanthomonas phaseoli pv. manihotis. PLoS One 2023; 18:e0285491. [PMID: 37167330 PMCID: PMC10174486 DOI: 10.1371/journal.pone.0285491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2022] [Accepted: 04/25/2023] [Indexed: 05/13/2023] Open
Abstract
Cassava Bacterial Blight (CBB) is a destructive disease widely distributed in the different areas where this crop is grown. Populations studies have been performed at local and national scales revealing a geographical genetic structure with temporal variations. A global epidemiology analysis of its causal agent Xanthomonas phaseoli pv. manihotis (Xpm) is needed to better understand the expansion of the disease for improving the monitoring of CBB. We targeted new tandem repeat (TR) loci with large repeat units, i.e. minisatellites, that we multiplexed in a scheme of Multi-Locus Variable number of TR Analysis (MLVA-8). This genotyping scheme separated 31 multilocus haplotypes in three clusters of single-locus variants and a singleton within a worldwide collection of 93 Xpm strains isolated over a period of fifty years. The major MLVA-8 cluster 1 grouped strains originating from all countries, except the unique Chinese strain. On the contrary, all the Xpm strains genotyped using the previously developed MLVA-14 microsatellite scheme were separated as unique haplotypes. We further propose an MLVA-12 scheme which takes advantage of combining TR loci with different mutation rates: the eight minisatellites and four faster evolving microsatellite markers, for global epidemiological surveillance. This MLVA-12 scheme identified 78 haplotypes and separated most of the strains in groups of double-locus variants (DLV) supporting some phylogenetic relationships. DLV groups were subdivided into closely related clusters of strains most often sharing the same geographical origin and isolated over a short period, supporting epidemiological relationships. The main MLVA-12 DLV group#1 was composed by strains from South America and all the African strains. The MLVA-12 scheme combining both minisatellite and microsatellite loci with different discriminatory power is expected to increase the accuracy of the phylogenetic signal and to minimize the homoplasy effects. Further investigation of the global epidemiology of Xpm will be helpful for a better control of CBB worldwide.
Collapse
Affiliation(s)
- Leidy Rache
- Department of Biological Sciences, Universidad de los Andes, Bogotá D.C., Colombia
| | - Laurence Blondin
- CIRAD, UMR PHIM, Montpellier, France
- Plant Health Institute of Montpellier (PHIM), Université Montpellier, IRD, CIRAD, INRAE, Institut Agro, Montpellier, France
| | - Paula Diaz Tatis
- Facultad de Ciencias, Universidad Antonio Nariño, Bogotá, Colombia
| | - Carolina Flores
- Plant Health Institute of Montpellier (PHIM), Université Montpellier, IRD, CIRAD, INRAE, Institut Agro, Montpellier, France
| | - Andrea Camargo
- Facultad de Ciencias, Universidad Antonio Nariño, Bogotá, Colombia
| | - Moussa Kante
- Plant Health Institute of Montpellier (PHIM), Université Montpellier, IRD, CIRAD, INRAE, Institut Agro, Montpellier, France
| | - Issa Wonni
- INERA, LMI Pathobios, Bobo Dioulasso, Burkina Faso
| | - Camilo López
- Departamento de Biología, Universidad Nacional de Colombia, Bogotá, Colombia
| | - Boris Szurek
- Plant Health Institute of Montpellier (PHIM), Université Montpellier, IRD, CIRAD, INRAE, Institut Agro, Montpellier, France
| | - Stephane Dupas
- Department of Biological Sciences, Universidad de los Andes, Bogotá D.C., Colombia
| | | | - Ralf Koebnik
- Plant Health Institute of Montpellier (PHIM), Université Montpellier, IRD, CIRAD, INRAE, Institut Agro, Montpellier, France
| | - Silvia Restrepo
- Department of Biological Sciences, Universidad de los Andes, Bogotá D.C., Colombia
| | - Adriana Bernal
- Department of Biological Sciences, Universidad de los Andes, Bogotá D.C., Colombia
| | - Christian Vernière
- Plant Health Institute of Montpellier (PHIM), Université Montpellier, IRD, CIRAD, INRAE, Institut Agro, Montpellier, France
- CIRAD, UMR PVBMT, Saint-Pierre, La Réunion, France
| |
Collapse
|
7
|
Karpowicz M, Świsłocka M, Sługocki Ł, Czerniawski R, López C, Kornijów R. Distribution of Diaphanosoma (Diplostraca: Sididae) genus in Central Europe – morphological and molecular approach. The European Zoological Journal 2022. [DOI: 10.1080/24750263.2022.2120106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022] Open
Affiliation(s)
- M. Karpowicz
- Department of Hydrobiology, Faculty of Biology, University of Białystok, Białystok, Poland
| | - M. Świsłocka
- Department of Zoology and Genetics, Faculty of Biology, University of Białystok, Białystok, Poland
| | - Ł. Sługocki
- Department of Hydrobiology, Institute of Biology, University of Szczecin, Szczecin, Poland
| | - R. Czerniawski
- Department of Hydrobiology, Institute of Biology, University of Szczecin, Szczecin, Poland
| | - C. López
- Escuela Superior Politécnica del Litoral (ESPOL), Centro de Agua y Desarrollo Sustentable, Guayaquil, Ecuador
| | - R. Kornijów
- Department of Fisheries Oceanography and Marine Ecology, National Marine Fisheries Research Institute, Gdynia, Poland
| |
Collapse
|
8
|
Meza V, López C, Kameid G, Manosalvas D, Giménez B, De Marinis R. [Bilateral posterior glenohumeral fracture-dislocation secondary to a seizure episode: the importance of early diagnosis. A case review]. Acta Ortop Mex 2022; 36:242-247. [PMID: 36977644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 03/30/2023]
Abstract
INTRODUCTION posterior glenohumeral fracture dislocation (PGHFD) is a rare injury. It may present secondary to a seizure, electrocution or due to direct trauma. It is usually missed, and late diagnosis is common which increases the rate of complications and sequalae. CASE REPORT 52 year old male, transferred to a reference trauma center due to a tonic-clonic seizure and a right PGHFD. Upon admission radiographs are requested and right shoulder injury is confirmed. Additionally, a simple left posterior glenohumeral dislocation (that was missed in the initial assessment of the patient) is observed. A computed tomography (CT) scan is obtained for both shoulders to plan surgery. The CT scan showed a bilateral PGHFD with severe comminution in the left shoulder, showing considerable worsening of the left shoulder since admission. Open reduction and bilateral locked plate osteosynthesis were performed in a one stage surgery. At two years follow up the patient evolved favorably with a Quick DASH score of 5% and a CONSTANT score of 72 and 76 for his right and left shoulder, respectively. CONCLUSION PGHFD is an infrequent injury, which requires a high level of suspicion to avoid diagnostic delay and prevent complications and sequelae. Bilateral cases may be seen in cases of seizure. With prompt surgical treatment, satisfactory results can be achieved with a complete return to normal activities.
Collapse
Affiliation(s)
- V Meza
- Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - C López
- Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - G Kameid
- Servicio de Traumatología, Hospital «Dr. Sótero del Río», Santiago, Chile
| | - D Manosalvas
- Servicio de Traumatología, Hospital «Dr. Sótero del Río», Santiago, Chile
| | - B Giménez
- Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - R De Marinis
- Departamento de Ortopedia y Traumatología, Pontificia Universidad Católica de Chile, Santiago, Chile
- Servicio de Traumatología, Hospital «Dr. Sótero del Río», Santiago, Chile
| |
Collapse
|
9
|
Remesar S, Otero JL, Panadero R, Díez-Baños P, Díaz P, García-Díos D, Martínez-Calabuig N, Morrondo MP, Alonso F, López C. Traumatic myiasis by Wohlfahrtia magnifica in sheep flocks from southeastern Spain: prevalence and risk factors. Med Vet Entomol 2022; 36:30-37. [PMID: 34545951 DOI: 10.1111/mve.12548] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2021] [Revised: 08/29/2021] [Accepted: 09/05/2021] [Indexed: 06/13/2023]
Abstract
Wohlfahrtia magnifica (Diptera: Sarcophagidae) is an obligate myiasis-causing fly of livestock that is widely distributed throughout the Mediterranean basin. A total of 73 683 sheep from 122 flocks in Albacete Province (southeastern [SE] Spain) were examined to detect active traumatic myiasis. The influence of several individual and flock factors on the prevalence was also assessed. The overall flock prevalence of traumatic myiasis was 95.9%, with an individual prevalence of 7.1%. Wohlfahrtia magnifica was identified in all of the positive animals except one that was infested by Lucilia sericata (Diptera: Calliphoridae). Adults of both genders showed a higher risk of infestation than juveniles, whereas males of all ages displayed an increased risk of infestation than females of all ages; the existence of a lambing building on the farm, poor husbandry facilities and the location area were also identified as risk factors. Prevalence was highest in the summer, and the fly season lasted from March to November. Genitalia were the main location of infestation in males (94.4%) and females (76.3%). Our results reveal that traumatic myiasis by W. magnifica is widespread in southeastern Spain, hence preventive measures minimizing the attractiveness of sheep to gravid flies are necessary to avoid health and welfare problems and significant production losses in sheep flocks.
Collapse
Affiliation(s)
- S Remesar
- INVESAGA Group, Department of Animal Pathology, Faculty of Veterinary, University Santiago de Compostela, Lugo, Spain
| | - J L Otero
- Departament of Animal Health, Faculty of Veterinary, University of Murcia, Murcia, Spain
| | - R Panadero
- INVESAGA Group, Department of Animal Pathology, Faculty of Veterinary, University Santiago de Compostela, Lugo, Spain
| | - P Díez-Baños
- INVESAGA Group, Department of Animal Pathology, Faculty of Veterinary, University Santiago de Compostela, Lugo, Spain
| | - P Díaz
- INVESAGA Group, Department of Animal Pathology, Faculty of Veterinary, University Santiago de Compostela, Lugo, Spain
| | - D García-Díos
- INVESAGA Group, Department of Animal Pathology, Faculty of Veterinary, University Santiago de Compostela, Lugo, Spain
| | - N Martínez-Calabuig
- INVESAGA Group, Department of Animal Pathology, Faculty of Veterinary, University Santiago de Compostela, Lugo, Spain
| | - M P Morrondo
- INVESAGA Group, Department of Animal Pathology, Faculty of Veterinary, University Santiago de Compostela, Lugo, Spain
| | - F Alonso
- Departament of Animal Health, Faculty of Veterinary, University of Murcia, Murcia, Spain
| | - C López
- INVESAGA Group, Department of Animal Pathology, Faculty of Veterinary, University Santiago de Compostela, Lugo, Spain
| |
Collapse
|
10
|
Noé E, Gómez A, Bernabeu M, Quemada I, Rodríguez R, Pérez T, López C, Laxe S, Colomer C, Ríos M, Juárez-Belaúnde A, González C, Pelayo R, Ferri J. Guía: Principios básicos de la neurorrehabilitación del paciente con daño cerebral adquirido. Recomendaciones de la Sociedad Española de Neurorrehabilitación. Neurologia 2021. [DOI: 10.1016/j.nrl.2021.06.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
11
|
Grande E, Garcia-Carbonero R, Teule A, Benavent Viñuales M, Jimenez-Fonseca P, Molina-Cerrillo J, López C, Custodio A, Hierro C, Gallego J, Alonso V, Carmona-Bayonas A, Llanos M, Sevilla I, Hernando J, Lista F, Antón Pascual B, Ruffinelli J, Gallego Jiménez I, Capdevila J. 575TiP Cabozantinib plus atezolizumab in advanced and progressive neoplasms of the endocrine system: A multicohort phase II trial (CABATEN trial / GETNE-T1914). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.710] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
12
|
Garcia-Carbonero R, Benavent M, Jiménez Fonseca P, Castellano D, Alonso-Gordoa T, Teulé A, Custodio A, Tafuto S, La Casta A, Spada F, López C, Ibrahim T, Silva MV, Iranzo V, García-Alfonso P, González-Flores E, Grande E, Crespo G, Carmona-Bayonas A, Capdevila J. 1097O The AXINET trial (GETNE1107): Axitinib plus octreotide LAR improves PFS by blinded central radiological assessment vs placebo plus octreotide LAR in G1-2 extrapancreatic NETs. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.179] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
13
|
Capdevila J, Landolfi S, Hernando J, Teule A, Garcia-Carbonero R, Custodio A, Cubillo A, Alonso-Gordoa T, Carmona-Bayonas A, Crespo G, Blanco M, Viudez A, La Casta A, Sevilla I, Segura Á, López C, Benavent Viñuales M, Nuciforo P, Manzano J. 1107P Durvalumab plus tremelimumab in patients with grade 3 neuroendocrine neoplasms of gastroenteropancreatic origin: Updated results from the multicenter phase II DUNE trial (GETNE 1601). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
14
|
Hernando J, Manzano J, Teule A, López C, Garcia-Carbonero R, Benavent Viñuales M, Custodio A, Cubillo A, Alonso V, Alonso-Gordoa T, Carmona-Bayonas A, Crespo G, Blanco M, Jimenez-Fonseca P, Viudez A, La Casta A, Sevilla I, Llanos M, Segura Á, Capdevila J. 1099MO Durvalumab plus tremelimumab influence on response to subsequent treatments in patients with neuroendocrine neoplasms (NENs) of gastroenteropancreatic and lung origins: Results from the phase II DUNE trial (GETNE 1601). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
15
|
Bühler MM, Kulis M, Duran‐Ferrer M, Clot G, Nadeu F, Navarro A, López C, Giné E, Beà S, Campo E, Martín‐Subero JI. A SIMPLE EPIGENETIC SIGNATURE DEFINES TWO BIOLOGIC GROUPS OF MANTLE CELL LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.58_2879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- M. M. Bühler
- Hospital Clínic Barcelona IDIBAPS Barcelona Spain
| | - M. Kulis
- Hospital Clínic Barcelona IDIBAPS Barcelona Spain
| | | | - G. Clot
- Hospital Clínic Barcelona IDIBAPS Barcelona Spain
| | - F. Nadeu
- Hospital Clínic Barcelona IDIBAPS Barcelona Spain
| | - A. Navarro
- Hospital Clínic Barcelona IDIBAPS Barcelona Spain
| | - C. López
- Hospital Clínic Barcelona IDIBAPS Barcelona Spain
| | - E. Giné
- Hospital Clínic Barcelona IDIBAPS Barcelona Spain
| | - S. Beà
- Hospital Clínic Barcelona IDIBAPS Barcelona Spain
| | - E. Campo
- Hospital Clínic Barcelona IDIBAPS Barcelona Spain
| | | |
Collapse
|
16
|
Martín Moro F, Martín Rubio I, Alonso R, López C, Marquet J, Herrera F, Delgado Trillo I, Herrera P, García Vela JA. THE ROLE OF MULTIPARAMETRIC FLOW CYTOMETRY IN DETECTING AND CHARACTERIZING GAMMA‐DELTA T‐CELL ENTITIES IN PERIPHERAL BLOOD. SINGLE‐CENTER CASE SERIES AND LITERATURE REVIEW. Hematol Oncol 2021. [DOI: 10.1002/hon.5_2881] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- F Martín Moro
- Hospital Universitario Ramón y Cajal Hematology Department Madrid Spain
| | - I Martín Rubio
- Hospital Universitario de Getafe Hematology Department Madrid Spain
| | - R Alonso
- Hospital Universitario de Getafe Hematology Department Madrid Spain
| | - C López
- Hospital Universitario de Getafe Hematology Department Madrid Spain
| | - J Marquet
- Hospital Universitario Ramón y Cajal Hematology Department Madrid Spain
| | - F Herrera
- Hospital Universitario de Getafe Hematology Department Madrid Spain
| | - I Delgado Trillo
- Hospital Universitario de Getafe Hematology Department Madrid Spain
| | - P Herrera
- Hospital Universitario Ramón y Cajal Hematology Department Madrid Spain
| | - J. A García Vela
- Hospital Universitario de Getafe Hematology Department Madrid Spain
| |
Collapse
|
17
|
Rivas‐Delgado A, López C, Nadeu F, Grau M, Rivero A, Bosch J, Alcoceba M, Gustavo T, Luizaga L, Barcena C, Kelleher N, Martin S, Mozas P, Balague O, Frigola G, Magnano L, Baumann T, Villamor N, Muntañola A, Sancho JM, García‐Sancho AM, Gonzalez‐Barca E, Climent F, Campo E, Giné E, López‐Guillermo A, Beà S. TESTICULAR DIFFUSE LARGE B‐CELL LYMPHOMA: CLINICO‐BIOLOGICAL CHARACTERIZATION, EVALUATION OF TREATMENT RESPONSE AND SURVIVAL. Hematol Oncol 2021. [DOI: 10.1002/hon.15_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- A. Rivas‐Delgado
- Hospital Clínic de Barcelona Hematology and Pathology Departments Barcelona Spain
| | - C. López
- Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS) Molecular pathology of lymphoid neoplasms Barcelona Spain
| | - F. Nadeu
- Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS) Molecular pathology of lymphoid neoplasms Barcelona Spain
| | - M. Grau
- Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS) Molecular pathology of lymphoid neoplasms Barcelona Spain
| | - A. Rivero
- Hospital Clínic de Barcelona Hematology and Pathology Departments Barcelona Spain
| | - J. Bosch
- Hospital de Bellvitge IDIBELL Pathology Department Barcelona Spain
| | - M. Alcoceba
- Hospital Universitario de Salamanca Hematology Department Salamanca Spain
| | - T. Gustavo
- ICO‐IJC‐Hospital Universitari Germans Trias i Pujol Hematology and Pathology Departments Badalona Spain
| | - L. Luizaga
- Hospital Universitari Mutua de Terrassa Hematology and Pathology Departments Terrasa Spain
| | - C. Barcena
- Hospital Universitario 12 de Octubre Hematology and Pathology Departments Madrid Spain
| | - N. Kelleher
- Institut Català d'Oncologia‐Hospital de Palamos Hematology Department Girona Spain
| | - S. Martin
- Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS) Molecular pathology of lymphoid neoplasms Barcelona Spain
| | - P. Mozas
- Hospital Clínic de Barcelona Hematology and Pathology Departments Barcelona Spain
| | - O. Balague
- Hospital Clínic de Barcelona Hematology and Pathology Departments Barcelona Spain
| | - G. Frigola
- Hospital Clínic de Barcelona Hematology and Pathology Departments Barcelona Spain
| | - L. Magnano
- Hospital Clínic de Barcelona Hematology and Pathology Departments Barcelona Spain
| | - T. Baumann
- Hospital Universitario 12 de Octubre Hematology and Pathology Departments Madrid Spain
| | - N. Villamor
- Hospital Clínic de Barcelona Hematology and Pathology Departments Barcelona Spain
| | - A. Muntañola
- Hospital Universitari Mutua de Terrassa Hematology and Pathology Departments Terrasa Spain
| | - J. M. Sancho
- ICO‐IJC‐Hospital Universitari Germans Trias i Pujol Hematology and Pathology Departments Badalona Spain
| | | | - E. Gonzalez‐Barca
- Institut Català d’Oncologia‐Hospital Duran i Reynals IDIBELL Universitat de Barcelona Hematology Department L'Hospitalet de Llobregat Spain
| | - F. Climent
- Hospital de Bellvitge IDIBELL Pathology Department Barcelona Spain
| | - E. Campo
- Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS) Molecular pathology of lymphoid neoplasms Barcelona Spain
| | - E. Giné
- Hospital Clínic de Barcelona Hematology and Pathology Departments Barcelona Spain
| | - A. López‐Guillermo
- Hospital Clínic de Barcelona Hematology and Pathology Departments Barcelona Spain
| | - S. Beà
- Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS) Molecular pathology of lymphoid neoplasms Barcelona Spain
| |
Collapse
|
18
|
Martín Moro F, Marquet Palomanes J, Delgado Trillo I, Piris Villaespesa M, López C, Herrera F, Rodríguez Martín E, Martínez Lorca A, García‐Cosío Piqueras M, Roldán Santiago E, García Marco JA, López Jiménez FJ, García Vela JA. FINDING A CONCORDANT OR DISCORDANT BONE MARROW INVOLVEMENT BY HISTOLOGY OR FLOW CYTOMETRY AT DLBCL NOS DIAGNOSIS IMPLIES A WORSE PROGNOSIS WHEREAS PET‐FDG DOES NOT. Hematol Oncol 2021. [DOI: 10.1002/hon.82_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- F. Martín Moro
- Hospital Universitario Ramón y Cajal Hematology Department Madrid Spain
| | | | | | | | - C. López
- Hospital Universitario de Getafe Hematology Department Madrid Spain
| | - F. Herrera
- Hospital Universitario de Getafe Hematology Department Madrid Spain
| | | | - A. Martínez Lorca
- Hospital Universitario Ramón y Cajal Nuclear Medicine Department Madrid Spain
| | | | | | - J. A. García Marco
- Hospital Universitario Puerta de Hierro Hematology Department Madrid Spain
| | | | | |
Collapse
|
19
|
Martín Moro F, Marquet Palomanes J, González Rodríguez A, Delgado Trillo I, López C, Herrera F, Villarrubia Espinosa J, Moreno Jiménez G, García Vela JA, López Jiménez FJ. A SINGLE BLOOD TEST IS ABLE TO CLASSIFY DLBCL PATIENTS IN THREE PROGNOSTIC CLUSTERS AT DIAGNOSIS. Hematol Oncol 2021. [DOI: 10.1002/hon.81_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- F. Martín Moro
- Hospital Universitario Ramón y Cajal Hematology Department Madrid Spain
| | | | | | | | - C. López
- Hospital Universitario de Getafe Hematology Department Madrid Spain
| | - F. Herrera
- Hospital Universitario de Getafe Hematology Department Madrid Spain
| | | | - G. Moreno Jiménez
- Hospital Universitario Ramón y Cajal Hematology Department Madrid Spain
| | | | | |
Collapse
|
20
|
Castillo-Franz C, López C, Carmona J. Evaluation of the Catabolic and Anabolic Gene Expression Effects and Histology Changes induced by Platelet-Rich Gel Supernatants in Equine Suspensory Ligament Explants Challenged with Lipopolysaccharide. Muscles Ligaments Tendons J 2021. [DOI: 10.32098/mltj.01.2021.01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- C. Castillo-Franz
- Grupo de Investigación Terapia Regenerativa, Department of Animal Health, University of Caldas, Manizales, Colombia
- Grupo de Investigación en Medicina Veterinaria GIVET, Lasallista University Corporation, Caldas, Antioquia, Colombia
- CONICYT National Doctoral Fellow, PhD Program in Veterinary Sciences, Graduate School, Veterinary Sciences School, Austral University of Chile, Campus Isla Teja S/N, Valdivia, Chile
| | - C. López
- Grupo de Investigación Terapia Regenerativa, Department of Animal Health, University of Caldas, Manizales, Colombia
| | - J.U. Carmona
- Grupo de Investigación Terapia Regenerativa, Department of Animal Health, University of Caldas, Manizales, Colombia
| |
Collapse
|
21
|
Herranz L, Pellegrini M, Lind T, Sonnenkalb M, Godin-Jacqmin L, López C, Dolganov K, Cousin F, Tamaki H, Kim T, Hoshi H, Andrews N, Sevon T. Overview and outcomes of the OECD/NEA benchmark study of the accident at the Fukushima Daiichi NPS (BSAF) Phase 2 – Results of severe accident analyses for Unit 1. Nuclear Engineering and Design 2020. [DOI: 10.1016/j.nucengdes.2020.110849] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
22
|
López C, Soto LM, Lafuente W, García M, Rocha-S FD, de Los Ríos P. First record of Diaphanosoma spinulosum Herbst 1975 (Cladocera: Sididae) for inland water bodies of Ecuador. BRAZ J BIOL 2020; 81:835-837. [PMID: 32876172 DOI: 10.1590/1519-6984.229455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2019] [Accepted: 03/18/2020] [Indexed: 11/21/2022] Open
Affiliation(s)
- C López
- Universidad Técnica de Manabí, Facultad de Ciencias Veterinarias, Escuela de Acuicultura y Pesqueria, Bahía de Caráquez, Manabí, Ecuador
| | - L M Soto
- Universidad Técnica de Manabí, Facultad de Ciencias Veterinarias, Escuela de Acuicultura y Pesqueria, Bahía de Caráquez, Manabí, Ecuador
| | - W Lafuente
- Universidad Estatal del Sur de Manabí, Facultad de Ciencias Naturales y de la Agricultura, Carrera de Ingeniería Ambiental, Manabí, Ecuador
| | - M García
- Universidad de Barcelona, Facultad de Biología, Barcelona, España
| | - F D Rocha-S
- Universidade Federal de Goiás - UFG, Laboratório de Taxonomia Animal, Unidade Acadêmica Especial de Ciências Biológicas, Regional Jataí, Jataí, GO, Brasil
| | - P de Los Ríos
- Universidad Católica de Temuco, Facultad de Recursos Naturales, Departamento de Ciencias Biológicas y Químicas, Temuco, Chile
| |
Collapse
|
23
|
Fonseca PJ, La Salvia A, Capdevila J, Castaño A, Benavent M, Alonso-Orduna V, Alonso T, Canovas MS, Custodio A, Centeno RG, Llanos M, Crespo G, Lopez de Sa A, Teule A, Fernández LO, Torres I, Plazas JG, Pericay C, Villabona C, López C. 1159MO Survival and prognostic factors analysis of 535 grade 3 gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN): Data from the Spanish Taskforce of Neuroendocrine Tumours Registry (R-GETNE). Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
24
|
Rubio XM, Diaz-Beveritge R, Sanchez JS, Pineda E, Salgado MV, Lecumberri M, Valverde C, Castro RL, López C, Echaburu JV, Salas NR, Bataller RDLP, Lopez RL, Rodriguez JM, Rodriguez-Antona C, Berraondo P, Rodriguez-Moreno J, Nuño AH, Sevillano E, Garcia-Donas J. 1069P A multicenter phase II study of nivolumab combined with ipilimumab in patients with pediatric solid tumours in adulthood (GETHI021). Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
25
|
Capdevila J, Teule A, López C, García-Carbonero R, Benavent M, Custodio A, Cubillo A, Alonso V, Gordoa TA, Carmona-Bayonas A, Crespo G, Blanco-Codesido M, Jimenez-Fonseca P, Viúdez A, La Casta Muñoa A, Sevilla I, Llanos M, Segura A, Hernando-Cubero J, Manzano J. 1157O A multi-cohort phase II study of durvalumab plus tremelimumab for the treatment of patients (pts) with advanced neuroendocrine neoplasms (NENs) of gastroenteropancreatic or lung origin: The DUNE trial (GETNE 1601). Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1370] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023] Open
|
26
|
Moreno Mochi P, Vargas JM, Vivaldo S, Bottiglieri M, López C, Mochi S, Cobos M, Castillo M, Del Campo R, Jure MA. Molecular epidemiology of methicillin-resistant Staphylococcus aureus from different population groups in Argentina. J Glob Antimicrob Resist 2020; 23:82-86. [PMID: 32763358 DOI: 10.1016/j.jgar.2020.07.016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2019] [Revised: 07/07/2020] [Accepted: 07/17/2020] [Indexed: 12/01/2022] Open
Abstract
OBJECTIVES In Latin America, methicillin-resistantStaphylococcus aureus (MRSA) is a leading cause of nosocomial infections. Limited studies have addressed the molecular epidemiology of MRSA clones in Argentina, characterised by continuous human migratory movements. The aim of this study was to describe the MRSA epidemiology, including distinct patient populations from different regions of the country. METHODS MRSA strains were collected in epidemiological studies conducted from 2009 to 2015 in three cities (Formosa, Córdoba and Tucumán) and involving four population groups: community adult patients; hospitalised adults; hospitalised children; and healthy children (nasal colonisation). Antimicrobial susceptibility testing, SCCmec and Panton-Valentine leukocidin (PVL) typing, pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) were performed. RESULTS A total of 120 MRSA isolates were recovered with an important population diversity in the groups studied; in community adult patients, MRSA isolates corresponded to ST5, ST267 and ST1619; from hospitalised adults they were ST97, ST5, ST72, ST125, ST200, ST647, ST747, ST935 and ST2941; from hospitalised children they were ST5, ST30, ST34, ST1163 and ST1619; and from colonised children they were ST5, ST125, ST34, ST100, ST1619, ST207 and ST1163. Results of SCCmec typing showed SCCmec I, SCCmec IIIA, SCCmec IV and SCCmec ND associated or not with PVL genes. CONCLUSIONS MRSA genetic lineages have differing distribution in the three regions. The most prevalent was ST5 in colonisation, community and invasive settings. Here we describe ST34-SCCmec IV clone for the first time in the hospitalised paediatric population. These findings contribute to the understanding of epidemiological changes in recent years.
Collapse
Affiliation(s)
- P Moreno Mochi
- Cátedra de Bacteriologia, Instituto de Microbiología Luis C. Verna, Fac. de Bioqcam, Qca y Fcia, Universidad Nacional de Tucumán, Ayacucho 491, San Miguel de Tucumán CP 4000, Argentina
| | - J M Vargas
- Cátedra de Bacteriologia, Instituto de Microbiología Luis C. Verna, Fac. de Bioqcam, Qca y Fcia, Universidad Nacional de Tucumán, Ayacucho 491, San Miguel de Tucumán CP 4000, Argentina
| | - S Vivaldo
- Hospital de la Madre y el Niño, Córdoba 1450, Formosa, CP 3600, Argentina
| | - M Bottiglieri
- Clínica Universitaria Reina Fabiola-Fundación para el Progreso de la UCC, Oncativo 1248, Córdoba, CP 5000, Argentina
| | - C López
- Centro de Microbiología Médica, Rondeau 877, San Miguel de Tucumán CP4000, Argentina
| | - S Mochi
- Hospital Ángel Cruz Padilla, Alberdi 540, San Miguel de Tucumán CP4000, Argentina
| | - M Cobos
- Servicio de Microbiología, Hospital Universitario Ramón y Cajal, and Instituto Ramón y Cajal de Investigaciones Sanitarias (IRYCIS), Madrid, Spain
| | - M Castillo
- Cátedra de Bacteriologia, Instituto de Microbiología Luis C. Verna, Fac. de Bioqcam, Qca y Fcia, Universidad Nacional de Tucumán, Ayacucho 491, San Miguel de Tucumán CP 4000, Argentina
| | - R Del Campo
- Servicio de Microbiología, Hospital Universitario Ramón y Cajal, and Instituto Ramón y Cajal de Investigaciones Sanitarias (IRYCIS), Madrid, Spain
| | - M A Jure
- Cátedra de Bacteriologia, Instituto de Microbiología Luis C. Verna, Fac. de Bioqcam, Qca y Fcia, Universidad Nacional de Tucumán, Ayacucho 491, San Miguel de Tucumán CP 4000, Argentina.
| |
Collapse
|
27
|
López C, Closa C, Lucas E. [Telemedicine in rehabilitation: Post-COVID need and opportunity]. Rehabilitacion (Madr) 2020; 54:225-227. [PMID: 32736803 PMCID: PMC7345413 DOI: 10.1016/j.rh.2020.06.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2020] [Accepted: 06/28/2020] [Indexed: 11/26/2022]
Affiliation(s)
- C López
- Servicio de Rehabilitación, Corporación Fisiogestión, Barcelona, España.
| | - C Closa
- Servicio de Rehabilitación, Corporación Fisiogestión, Barcelona, España
| | - E Lucas
- Servicio de Rehabilitación, Corporación Fisiogestión, Barcelona, España; Servicio de Rehabilitación, MC Mutual, Barcelona. España
| |
Collapse
|
28
|
Sibila M, Guevara G, Cuadrado R, Pleguezuelos P, Pérez D, Pérez de Rozas A, Huerta E, Llorens A, Valero O, Pérez M, López C, Krejci R, Segalés J. Comparison of Mycoplasma hyopneumoniae and porcine circovirus 2 commercial vaccines efficacy when applied separate or combined under experimental conditions. Porcine Health Manag 2020; 6:11. [PMID: 32391165 PMCID: PMC7197127 DOI: 10.1186/s40813-020-00148-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2019] [Accepted: 03/04/2020] [Indexed: 02/07/2023] Open
Abstract
Background Mycoplasma hyopneumoniae (Mhyo) and Porcine circovirus 2 (PCV-2) are two of the most significant infectious agents causing economic losses in the weaning to slaughter period. Due to their similar vaccination age, the objective of this study was to assess the efficacy of two already existing Mhyo (Hyogen®) and PCV-2 (Circovac®) vaccines when administered separately or combined (RTM) by means of Mhyo or PCV-2 experimental challenges. Results Seven groups of animals were included in the study, being three of them challenged with PCV-2, three with Mhyo and one composed of non-challenged, non-vaccinated pigs. Within each experimental challenge, non-vaccinated (NV) groups were compared with double vaccinated groups using the commercial products separated (VS) or combined (VC). Both vaccinated groups showed significant differences for most parameters measured regarding PCV-2 (serology, percentage of infected animals and viral load in tissues) and Mhyo (serology and gross lesions) when compared to NV groups. VS and VC offered similar results, being only significantly different the PCV-2 antibody values at different time points (higher in the VS group) of the study, although not at the termination day (21 days post-PCV-2 inoculation). Conclusion The present study expands the knowledge on the possibility of using two separate Mhyo and PCV-2 commercial vaccines as a RTM product, which offered equivalent virological, immunological and pathological outcomes as compared to these vaccines when used by separate.
Collapse
Affiliation(s)
- M Sibila
- 1IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA- UAB), Campus de la Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.,OIE Collaborating Centre for the Research and Control of Emerging and Re-emerging Swine Diseases in Europe (IRTA-CReSA), Bellaterra, Barcelona, Spain
| | - G Guevara
- 1IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA- UAB), Campus de la Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.,OIE Collaborating Centre for the Research and Control of Emerging and Re-emerging Swine Diseases in Europe (IRTA-CReSA), Bellaterra, Barcelona, Spain
| | - R Cuadrado
- 1IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA- UAB), Campus de la Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.,OIE Collaborating Centre for the Research and Control of Emerging and Re-emerging Swine Diseases in Europe (IRTA-CReSA), Bellaterra, Barcelona, Spain
| | - P Pleguezuelos
- 1IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA- UAB), Campus de la Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.,OIE Collaborating Centre for the Research and Control of Emerging and Re-emerging Swine Diseases in Europe (IRTA-CReSA), Bellaterra, Barcelona, Spain
| | - D Pérez
- 1IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA- UAB), Campus de la Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.,OIE Collaborating Centre for the Research and Control of Emerging and Re-emerging Swine Diseases in Europe (IRTA-CReSA), Bellaterra, Barcelona, Spain
| | - A Pérez de Rozas
- 1IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA- UAB), Campus de la Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.,OIE Collaborating Centre for the Research and Control of Emerging and Re-emerging Swine Diseases in Europe (IRTA-CReSA), Bellaterra, Barcelona, Spain
| | - E Huerta
- 1IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA- UAB), Campus de la Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.,OIE Collaborating Centre for the Research and Control of Emerging and Re-emerging Swine Diseases in Europe (IRTA-CReSA), Bellaterra, Barcelona, Spain
| | - A Llorens
- 1IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA- UAB), Campus de la Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.,OIE Collaborating Centre for the Research and Control of Emerging and Re-emerging Swine Diseases in Europe (IRTA-CReSA), Bellaterra, Barcelona, Spain
| | - O Valero
- 3Servei d'Estadística Aplicada, Universitat Autònoma de Barcelona, Campus de la Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain
| | - M Pérez
- 1IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA- UAB), Campus de la Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.,OIE Collaborating Centre for the Research and Control of Emerging and Re-emerging Swine Diseases in Europe (IRTA-CReSA), Bellaterra, Barcelona, Spain
| | - C López
- 1IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA- UAB), Campus de la Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.,OIE Collaborating Centre for the Research and Control of Emerging and Re-emerging Swine Diseases in Europe (IRTA-CReSA), Bellaterra, Barcelona, Spain.,4Departament de Sanitat i Anatomia Animals, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain
| | - R Krejci
- 5Ceva, La Ballastiere-BP, 126, 33501 Libourne Cedex, France
| | - J Segalés
- OIE Collaborating Centre for the Research and Control of Emerging and Re-emerging Swine Diseases in Europe (IRTA-CReSA), Bellaterra, Barcelona, Spain.,4Departament de Sanitat i Anatomia Animals, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.,6UAB, Centre de Recerca en Sanitat Animal (CReSA, IRTA- UAB), Campus de la Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain
| |
Collapse
|
29
|
López C, Sánchez JL, Martín J. [Exploratory analysis of the influence of cognitive reserve on the benefits of cognitive stimulation therapy in patients with sporadic late-onset Alzheimer's disease]. Rev Neurol 2020; 70:271-281. [PMID: 32242333 DOI: 10.33588/rn.7008.2019420] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
INTRODUCTION The main objective of cognitive stimulation therapies is to promote the plasticity and learning ability that the individual is still in possession of in old age and to delay the clinical manifestations of neurodegenerative processes such as Alzheimer-type dementia. There are variables that can mediate the benefits of the intervention, such as the cognitive reserve. AIM To determine whether there is an interaction between the level of reserve and cognitive stimulation, and if it influences the cognitive performance of subjects with Alzheimer-type dementia. PATIENTS AND METHODS Twenty subjects (age: 66-89) with Alzheimer-type dementia who attend a day centre participated in the study. A pretest-posttest controlled design was used. The pilot group took part in the intervention for six months. Patients were classified into two levels of cognitive reserve (high and low) and then a broad neuropsychological battery was applied to perform a comprehensive analysis of cognition. Pre- and post-intervention differences were analysed through a two-factor ANOVA, one with repeated measures (pre- and post-intervention scores) and another with independent measures (level of cognitive reserve). RESULTS Interaction was found in the scores on the picture arrangement subtests (WAIS-III), failure to maintain the category and the percentage of errors in the Wisconsin Card Sorting Test. CONCLUSIONS The positive effect of the interaction on the executive function has been observed, specifically in the capacities for planning and sequencing, perceptual organisation, response inhibition, logical reasoning and mental flexibility.
Collapse
Affiliation(s)
- C López
- Universidad de Salamanca, 37005 Salamanca, España
| | - J L Sánchez
- Universidad de Salamanca, 37005 Salamanca, España
| | - J Martín
- Universidad de Salamanca, 37005 Salamanca, España
| |
Collapse
|
30
|
Hernández I, Estrella A, Salazar J, Duarte Y, Torres E, López C, Terán S, Mendoza A, Terán E. Treatment Eligibility and Therapeutic Responses of an Ecuadorian Population at High Cardiovascular Risk Based on the ATP III Guidelines. IJCS 2020. [DOI: 10.36660/ijcs.20190010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
31
|
Álvarez-Lueje A, López C, Núñez-Vergara LJ, Squella JA. Voltammetric Behavior and Analytical Applications of Lomefloxacin, an Antibacterial Fluorquinolone. J AOAC Int 2019. [DOI: 10.1093/jaoac/84.3.649] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
Lomefloxacin was reduced on a dropping mercury electrode, producing one or more peaks, depending on the pH of the aqueous medium. Coulometric measurements gave an experimental value of 1 electron for the main peak. Electrolysis was followed by UV spectrophotometry and liquid chromatography (LC), showing that a new band at 413 nm appeared for the electrolysis product in an acidic medium. Furthermore, by using UV spectrophotometry, an apparent pKa value of 6.75 ± 0.05 was obtained for lomefloxacin corresponding to the carboxyl moiety in the 3-position. For analytical studies, the differential pulse polarographic mode in 0.1N HCl was selected. The repeatability and reproducibility of the method were adequate (coefficient of variation [CV], 0.51%). The calibration curve method was used for the lomefloxacin concentration range of 7.0 × 10−6 to 7.0 × 10−5M. The detection and quantitation limits were 1.0 × 10−6 and 6.9 × 10−6M, respectively. For purposes of comparison, both UV spectrophotometric and LC (with UV and fluorimetric detection) methods were developed. The polarographic method showed good selectivity with respect to both excipients and degradation products. The recovery study showed a CV of <2% and an average recovery of 99.5% and it was not necessary to treat the sample before analysis. The method was applied to the determination of the uniformity content of lomefloxacin commercial tablets. The polarographic method was also successfully applied to the quantitation of lomefloxacin in urine, and the renal excretion profile was also determined.
Collapse
Affiliation(s)
- Alejandro Álvarez-Lueje
- University of Chile, Chemical and Pharmaceutical Sciences Faculty, Bioelectrochemistry Laboratory, PO Box 233, Santiago 1, Chile
| | - Camilo López
- University of Chile, Chemical and Pharmaceutical Sciences Faculty, Bioelectrochemistry Laboratory, PO Box 233, Santiago 1, Chile
| | - Luis J Núñez-Vergara
- University of Chile, Chemical and Pharmaceutical Sciences Faculty, Bioelectrochemistry Laboratory, PO Box 233, Santiago 1, Chile
| | - Juan A Squella
- University of Chile, Chemical and Pharmaceutical Sciences Faculty, Bioelectrochemistry Laboratory, PO Box 233, Santiago 1, Chile
| |
Collapse
|
32
|
Díaz P, Remesar S, Venzal JM, Vázquez-López ME, Fernández G, López C, Díez-Baños P, Morrondo P, Panadero R. Occurrence of Borrelia and Borreliella species in Ixodes ricinus collected from roe deer in northwestern Spain. Med Vet Entomol 2019; 33:427-430. [PMID: 30730054 DOI: 10.1111/mve.12364] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/02/2018] [Revised: 12/11/2018] [Accepted: 12/19/2018] [Indexed: 06/09/2023]
Abstract
Ixodes ricinus, comprising the predominant tick species in Europe, can transmit important human pathogens, including Borreliella spp., the causal agent of Lyme borreliosis. One hundred and seventy five roe deer hunted in two areas (plateau and mountain) of Galicia (northwest Spain) were examined for the presence of ticks; all roe deer were infested by I. ricinus. Nymphs (n = 1000), males (n = 1449) and females (n = 1000) of I. ricinus were analysed in pools of up to 10 ticks to detect both Borreliella and Borrelia DNA. The average number of I. ricinus per roe deer was similar in both areas, regardless of the life stage; although the percentage of Borreliella and Borrelia positive pools was higher in ticks collected from roe deer hunted in the plateau area, no significant differences were detected. Sequence analysis at the flagellin gene allowed the identification of four Borreliella species (Borreliella afzelii, Borreliella garinii, Borreliella lusitaniae and Borreliella valaisiana) and Borrelia miyamotoi in adult males; only B. valaisiana and B. miyamotoi were detected in nymphs and all females were negative. All Borreliella and Borrelia species found in roe deer were previously identified in questing I. ricinus collected in the same study area, although the prevalence was lower in the present study. The analysis of male I. ricinus ticks collected from roe deer gives a good estimation of Borreliella diversity in questing ticks.
Collapse
Affiliation(s)
- P Díaz
- Facultad de Veterinaria, Departamento de Patología Animal (Grupo INVESAGA), Universidade de Santiago de Compostela, Lugo, Spain
| | - S Remesar
- Facultad de Veterinaria, Departamento de Patología Animal (Grupo INVESAGA), Universidade de Santiago de Compostela, Lugo, Spain
| | - J M Venzal
- Laboratorio de Vectores y enfermedades transmitidas, CENUR Litoral Norte, Universidad de la República, Salto, Uruguay
| | - M E Vázquez-López
- Servicio de Pediatría, Hospital Universitario Lucus Augusti, Lugo, Spain
| | - G Fernández
- Facultad de Veterinaria, Departamento de Patología Animal (Grupo INVESAGA), Universidade de Santiago de Compostela, Lugo, Spain
| | - C López
- Facultad de Veterinaria, Departamento de Patología Animal (Grupo INVESAGA), Universidade de Santiago de Compostela, Lugo, Spain
| | - P Díez-Baños
- Facultad de Veterinaria, Departamento de Patología Animal (Grupo INVESAGA), Universidade de Santiago de Compostela, Lugo, Spain
| | - P Morrondo
- Facultad de Veterinaria, Departamento de Patología Animal (Grupo INVESAGA), Universidade de Santiago de Compostela, Lugo, Spain
| | - R Panadero
- Facultad de Veterinaria, Departamento de Patología Animal (Grupo INVESAGA), Universidade de Santiago de Compostela, Lugo, Spain
| |
Collapse
|
33
|
Díaz JM, Prieto A, López G, Díaz P, López C, Quintela LÁ, Morrondo P, Fernández G. Association of Ureaplasma diversum with reproductive disease in cattle. N Z Vet J 2019; 67:249-256. [PMID: 31131738 DOI: 10.1080/00480169.2019.1623733] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Aims: To examine the association between the detection of Ureaplasma diversum in vaginal swabs from dairy cows in north western Spain with the diagnosis of granular vulvovaginitis (GVV) and reproductive performance, and the association with subclinical endometritis (SE) in slaughterhouse material. The presence of this microorganism in cases of abortion was also investigated. Methods: From 106 dairy farms in the province of Lugo, 40 herds were randomly selected. Vaginal swabs were obtained from 10 randomly selected cows per farm, then pooled for analysis to detect the presence of U. diversum by quantitative real-time PCR (qPCR). In five of these herds samples from the 10 animals were individually tested for U. diversum, and the presence of GVV lesions and their reproductive efficiency (number of inseminations to achieve pregnancy over two subsequent pregnancies) were determined. Vaginal swabs from uteri of cattle obtained at a slaughterhouse (n = 100) were tested for U. diversum and the presence of SE, defined as >5% polymorphonuclear cells in cytobrush smears, was determined. Sixteen farms with abortion problems submitted samples for culture and PCR testing including for U. diversum. Results: Of the 40 herds, 39 (98%) tested positive for U. diversum. On the five farms, 25/50 (50%) cows tested positive for U. diversum, and more cows with GGV-lesions (16/25; 64%) tested positive than cows without lesions (9/25; 36%) (p = 0.047). There were more cows with poor reproductive efficacy that tested positive (8/11; 57%) than tested negative (3/17; 18%) for U. diversum (p = 0.029). Of the 100 uteri, five tested positive for U. diversum and there were more uteri with SE that tested positive (3/19; 16%) than uteri without SE (2/81; 2%) (p = 0.036). U. diversum was also diagnosed in 4/16 farms with abortion problems and liver appeared to be the best tissue for detecting U. diversum DNA in the fetuses analysed. Conclusions and Clinical Relevance: Infection with U. diversum was present in most of herds investigated and it was statistically associated with GVV, SE and poor reproductive performance. It was also detected in abortions and the liver may also be an additional tissue to be considered in the diagnosis of U. diversum abortion by PCR. The possible association with different diseases in the same area suggests that different presentations should be considered when studying the implications of U. diversum on the reproductive diseases of cattle.
Collapse
Affiliation(s)
- J M Díaz
- a Department of Animal Pathology (INVESAGA Group), Faculty of Veterinary Sciences , Universidade de Santiago de Compostela , Lugo , Spain
| | - A Prieto
- a Department of Animal Pathology (INVESAGA Group), Faculty of Veterinary Sciences , Universidade de Santiago de Compostela , Lugo , Spain
| | - G López
- a Department of Animal Pathology (INVESAGA Group), Faculty of Veterinary Sciences , Universidade de Santiago de Compostela , Lugo , Spain
| | - P Díaz
- a Department of Animal Pathology (INVESAGA Group), Faculty of Veterinary Sciences , Universidade de Santiago de Compostela , Lugo , Spain
| | - C López
- a Department of Animal Pathology (INVESAGA Group), Faculty of Veterinary Sciences , Universidade de Santiago de Compostela , Lugo , Spain
| | - L Á Quintela
- b Unit of Reproduction & Obstetrics, Department of Animal Pathology, Faculty of Veterinary Sciences , Universidade de Santiago de Compostela , Lugo , Spain
| | - P Morrondo
- a Department of Animal Pathology (INVESAGA Group), Faculty of Veterinary Sciences , Universidade de Santiago de Compostela , Lugo , Spain
| | - G Fernández
- a Department of Animal Pathology (INVESAGA Group), Faculty of Veterinary Sciences , Universidade de Santiago de Compostela , Lugo , Spain
| |
Collapse
|
34
|
Hernández I, Barzallo J, Beltrán S, Castillo A, Cevallos N, Hernández P, López C, Vera R, Yerovi G, Mendoza A, Terán S, Izurieta A, Teran E. Increased incidences of noninfectious comorbidities among aging populations living with human immunodeficiency virus in Ecuador: a multicenter retrospective analysis. HIV AIDS (Auckl) 2019; 11:55-59. [PMID: 31114389 PMCID: PMC6489679 DOI: 10.2147/hiv.s193412] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Introduction: Besides the well-known increased risk of developing HIV-related infectious comorbidities; compared with the general population, people living with HIV (PLHIV) may also have an increased risk of developing noninfectious comorbidities (NICMs). This is the first study intended to determine the NICMs rates affecting PLHIV who were under cART regimen in Ecuador. Methods: A total of 503 HIV-positive patients were evaluated during the period June 2015-November 2016 and included in a multicenter retrospective, cross-sectional study conducted in seven main government and nongovernment community-based hospitals in Ecuador. Results: The average age of the participants was 39.2±11.9 years old and the majority of them were male (67.2%). The average age at HIV diagnosis was 34.1 years old and cART in average was started 15.9 months after HIV-diagnosis. Recruited patients were receiving cART for an average of 59.2±40.2 months. Only 9.9% (n=50) of the patients did not show any NICMs. Diabetes and pre-diabetes was found in 6% (n=30) and 16.3% (n=82) patients, respectively; however, dyslipidemia and overweight/obesity was frequent, as they affected 41.4% (n=208) and 36.4% (n=183) patients, respectively. Sixty patients (11.9%) were diagnosed with depression and 28.2% (n=142) of the studied subjects were found to have other NICMs. Conclusion: Prevalence of NICMs among subjects under cART was greater than that reported among the Ecuadorian general population, therefore specific public health actions are required to make patients aware of and prevent NICMs among PLHIV in Ecuador.
Collapse
Affiliation(s)
- Isabel Hernández
- Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Quito, Ecuador.,Facultad de Enfermería, Pontificia Universidad Católica del Ecuador, Quito, Ecuador
| | - Julio Barzallo
- Hospital Teofilo Dávila, Ministerio de Salud Pública, Machala, Ecuador
| | - Simón Beltrán
- Hospital Carlos Andrade Marín, Instituto Ecuatoriano de Seguridad Social, Quito, Ecuador
| | - Alberto Castillo
- Hospital Eugenio Espejo, Ministerio de Salud Pública, Quito, Ecuador
| | - Nelson Cevallos
- Hospital Enrique Garcés, Ministerio de Salud Pública, Quito, Ecuador
| | - Patricio Hernández
- Hospital de Infectología Dr. José Daniel Rodríguez Maridueña, Ministerio de Salud Pública, Guayaquil, Ecuador
| | - Camilo López
- Hospital Teodoro Maldonado Carbo, Instituto Ecuatoriano de Seguridad Social, Guayaquil, Ecuador
| | - Rita Vera
- Hospital Abel Gilbert Pontón, Ministerio de Salud Pública, Guayaquil, Ecuador
| | - Gabriela Yerovi
- Programa Nacional para Control del VIH, Ministerio de Salud Pública, Quito, Ecuador
| | - Alejandra Mendoza
- Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Quito, Ecuador
| | - Santiago Terán
- Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Quito, Ecuador
| | - Andres Izurieta
- Department of Computer Engineering, College of Engineering, University of South Florida, Tampa, FL, USA
| | - Enrique Teran
- Colegio de Ciencias de la Salud, Universidad San Francisco de Quito, Quito, Ecuador
| |
Collapse
|
35
|
Ibáñez SA, Carrillo J, Aguilar M, Laporta R, López C, Díaz G, Salas C, Ussetti M. Peripheral Blood Eosinophil Count as a Marker of Pulmonary Allograft Rejection. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.1027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
36
|
|
37
|
Morata A, Bañuelos M, López C, Chenli S, Vejarano R, Loira I, Palomero F, Lepe J. The oenological interest of fumaric acid: Stop malolactic fermentation and preserve the freshness of wines. BIO Web Conf 2019. [DOI: 10.1051/bioconf/20191502034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
One of the problems related to the increase in average temperatures in the wine-growing regions is the lower accumulation of organic acids in the berries. Wine freshness depends to a great extent on its acidity. Herein, the effectiveness of fumaric acid to inhibit malolactic fermentation or to stop it once initiated is evaluated in order to preserve the malic acid content. Different doses of fumaric acid and SO2 were tested. The ability of these compounds to inhibit bacterial development and stop the malic acid degradation was tested on a red wine of the variety Vitis vinifera L. cv. Tempranillo whose malic acid content was set at 1.5 g/L. The control wine inoculated with 6 log CFU/mL of Oenococcus oeni finished the malolactic fermentation in 12 days. However, the use of doses equal to or greater than 300 mg/L of fumaric acid delayed the onset of malolactic fermentation for more than 50 days with little degradation of malic acid. In addition, fumaric acid proved to be effective in stopping malolactic fermentation already started where the bacterial count was 7 log CFU/mL. Fumaric acid can be considered as a potent inhibitor of malolactic fermentation.
Collapse
|
38
|
Acevedo C, Romo S, López C, Cortes-Mcnealy A, Cruz-González MI, Parlange A, Kjelland ME. 88 Evaluation of embryo transfer results using embryos cryopreserved in ethylene glycol for 8 years or in glycerol for 30 years. Reprod Fertil Dev 2019. [DOI: 10.1071/rdv31n1ab88] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Various permeating cryoprotectants, such as glycerol and ethylene glycol, have been used in the cryopreservation of embryos to help maintain cellular viability during indefinite and prolonged periods of storage in liquid nitrogen. The objective of this study was to compare the efficiency of glycerol (G) and ethylene glycol (EG) after storage in liquid nitrogen for a considerable period of time before transfer. The work was carried out in Palenque, Chiapas, Mexico. A total of 50 embryos were transferred, 24 Brahman (G) cryopreserved in the 1990s and 26 Brangus (EG) cryopreserved in 2010. Synchronous recipients were selected based on 3 characteristics: body condition (5-7, scale of 1-9), reproductive health, and multiparity. Recipient cows (n=62) were synchronized using a FTET protocol as follows. On Day 0, cows received a progesterone intravaginal device (CIDR) and 2mg of oestradiol benzoate IM. On day 8, the CIDR was removed and all cows received 25mg of dinoprost tromethamine (Lutalyse, Pfizer Animal Health, Montreal, Quebec, Canada), 200IU of eCG, and 0.5mg oestradiol cipionate IM. Day 10 was considered the day of oestrus and embryos were transferred (n=50) to the ipsilateral uterine horn of those recipients with a corpus luteum greater than 1.5cm in diameter on Day 17. The G embryos were produced with 4 bulls whereas the EG embryos were produced with 6 different bulls. The G straws were thawed for 12s in the air plus 12s in 20°C water. Embryos were immersed for 8min in a thawing solution containing 1.0M sucrose (ViGRO One-Step) and then transferred to holding medium (ViGRO Holding) for rehydration before loading into straws for embryo transfer. The EG embryos were thawed by allowing the straws to stand in air for 10s and then immersing them in a 30°C water bath for 10s and were transferred immediately. Pregnancy diagnosis 35 days after the transfer revealed 19 pregnancies of 50 embryos transferred (38%), distributed as 46% embryos in EG (12 pregnant of 26 transferred) and 29% embryos in G (7 pregnant of 24). A Fisher’s exact test was performed showing that no significant difference existed between groups (P>0.05). There was no effect of bull on pregnancy rates, and Brahman breed results by individual bull were 5 pregnancies of 13 (38%), 2 of 6 (33%), 0 of 4 (0%), and 0 of 1 (0%) for bulls I to IV, respectively. Pregnancy rate by Brangus bulls were 6 pregnancies of 7 (86%), 2 of 3 (67%), 2 of 4 (50%), 2 of 4 (50%), 0 of 4 (0%), and 0 of 3 (0%) for bulls 1 to 6, respectively. It is important to remember that the embryos cryopreserved in G remained in the nitrogen tank for more than 30 years, whereas the embryos cryopreserved in EG remained stored in liquid nitrogen for less than 10 years. Although pregnancy rate was numerically lower with Brahman embryos stored in G, pregnancy rates were considered acceptable considering the length of storage. Future research is needed with greater numbers and different breeds to determine whether G or EG will consistently produce higher embryo viability and pregnancies after storage for considerable periods before transfer.
Collapse
|
39
|
González-Flores E, Serrano R, Sevilla I, Viúdez A, Barriuso J, Benavent M, Capdevila J, Jimenez-Fonseca P, López C, Garcia-Carbonero R. SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018). Clin Transl Oncol 2019; 21:55-63. [PMID: 30535553 PMCID: PMC6339660 DOI: 10.1007/s12094-018-1980-7] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2018] [Accepted: 11/07/2018] [Indexed: 12/13/2022]
Abstract
NENs are a heterogeneous family of tumors of challenging diagnosis and clinical management. Their incidence and prevalence continue to rise across all sites, stages and grades. Although improved diagnostic techniques have led to earlier detection and stage migration, the improved prognosis documented over time for advanced gastrointestinal and pancreatic neuroendocrine tumors also reflect improvements in therapy. The aim of this guideline is to update practical recommendations for the diagnosis and treatment of gastroenteropancreatic and lung NENs. Diagnostic procedures, histological classification and therapeutic options are briefly discussed, including surgery, liver-directed therapy, peptide receptor radionuclide therapy, and systemic hormonal, cytotoxic or targeted therapy, and treatment algorithms are provided.
Collapse
Affiliation(s)
- E. González-Flores
- Department of Medical Oncology, Hospital Universitario Virgen de las Nieves, Granada, Spain
| | - R. Serrano
- Department of Medical Oncology, Hospital Reina Sofía, Córdoba, IMIBIC, CIBERONC, Córdoba, Spain
| | - I. Sevilla
- Department of Medical Oncology, Instituto de Investigaciones Biomédicas de Málaga (IBIMA)/Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Málaga, Spain
| | - A. Viúdez
- Department of Medical Oncology, Complejo Hospitalario de Navarra (CHN), OncobionaTras Unit, Navarrabiomed, IdiSNA, Pamplona, Spain
| | - J. Barriuso
- Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
- Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
| | - M. Benavent
- Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina, Seville, Spain
| | - J. Capdevila
- Department of Medical Oncology, Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VIHO), Barcelona, Spain
| | - P. Jimenez-Fonseca
- Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain
| | - C. López
- Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain
| | - R. Garcia-Carbonero
- Department of Medical Oncology, Hospital Universitario 12 de Octubre, IIS imas12, UCM, CNIO, CIBERONC, Av. de Córdoba, s/n, 28041 Madrid, Spain
| |
Collapse
|
40
|
Villarroel-Espíndola F, Maldonado R, Mancilla H, Ramírez A, Vander K, Cereceda K, López C, Castro M, Angulo C, Slebe J, Concha I. The Many Faces of Carbohydrate Metabolism in Male Germ Cells: From Single Molecules to Active Polymers. ACTA ACUST UNITED AC 2018. [DOI: 10.32457/ijmss.2015.036] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Spermatogenesis is a complex physiological process that involves cell proliferation, meiotic division and a final cell differentiation of post-meiotic cells into spermatozoa. During this process male germ cells also undergo a metabolic differentiation process, in which post-meiotic spermatogenic cells (spermatids) but not meiotic spermatogenic cells (spermatocytes) respond differentially to D-glucose metabolism, glucose transporters (GLUTs) distribution and utilization of non-hexose substrates, such as lactate/pyruvate or dihydroxyacetone. These differences might be explained by the requirement for a specific metabolic process to support cell differentiation or in some cases, cell viability. In addition, though glycogen is considered to be the main glucose store, in male germ cells this polymer may play a novel role in cell proliferation, acting as a new marker for apoptotic events in testicular tissue via a yet unknown mechanism. In this article, we summarize the main metabolic changes that occur during male germ differentiation, with a specific focus on metabolic sources during spermatocyte to spermatid transition. The latter considering that these cells come from the same cell linage as specialized cells, but are not isolated from their environment, describing the roles from single molecules to polymers on the viability of male germ cells.
Collapse
|
41
|
Mielgo Rubio X, Sereno Moyano M, Chara L, López-Castro R, Rubio-Martínez J, Velastegui A, Olier-Garate C, Falagán S, Gómez-Barreda I, Riquelme A, Silva-Ruiz J, Moreno-Rubio J, López C, Bueno C, Cardeña A, Pérez-Fernández E, Martí-Castelló M, Sotelo-Lezama M. Neutrophil-platelet score (NPS), a predictive systemic inflammation score for PD-1 immune checkpoint inhibitors (ICI) in pretreated advanced non-small cell lung cancer (NSCLC) patients. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy292.035] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
42
|
Mielgo-Rubio X, Sereno Moyano M, Sotelo-Lezama M, Lopez Castro R, Rubio-Martínez J, Velastegui A, Olier-Garate C, Falagan S, Gómez-Barreda I, Riquelme A, Cardeña-Gutiérrez A, Moreno Rubio J, López C, Bueno C, Silva-Ruiz J, Zhan Zhou E, Chara L. P1.01-69 Validation of the Lung Immune Prognostic Index (LIPI): Useful to Identify Resistance to PD-1 Checkpoint Inhibitors in Pretreated Lung Cancer. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.625] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
43
|
Coindreau O, Jäckel B, Rocchi F, Alcaro F, Angelova D, Bandini G, Barnak M, Behler M, Da Cruz D, Dagan R, Drai P, Ederli S, Herranz L, Hollands T, Horvath G, Kaliatka A, Kljenak I, Kotsuba O, Lind T, López C, Mancheva K, Matejovic P, Matkovič M, Steinbrück M, Stempniewicz M, Thomas R, Vileiniskis V, Visser D, Vokáč P, Vorobyov Y, Zhabin O. Severe accident code-to-code comparison for two accident scenarios in a spent fuel pool. ANN NUCL ENERGY 2018. [DOI: 10.1016/j.anucene.2018.06.043] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
44
|
Rey L, Visiedo L, López C, Álvaro E, Tortajada B, Abilés J. Case-control study of patients carrying a gastrostomy tube with a nutritional approach. Clin Nutr 2018. [DOI: 10.1016/j.clnu.2018.06.1805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
45
|
Gimeno E, Bárcenas I, Serrano E, Villena A, Trigo E, Carriles S, López C, Normand E, Garzonio A, Chiclana C. 252 Facing the transition changes in the puerperium. Couples experience. J Sex Med 2018. [DOI: 10.1016/j.jsxm.2018.04.217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
46
|
Pérez J, Llanos J, Sáez C, López C, Cañizares P, Rodrigo M. The pressurized jet aerator: A new aeration system for high-performance H2O2 electrolyzers. Electrochem commun 2018. [DOI: 10.1016/j.elecom.2018.02.012] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
47
|
Carmona-Bayonas A, Jiménez-Fonseca P, Custodio A, Sánchez Cánovas M, Hernández R, Pericay C, Echavarria I, Lacalle A, Visa L, Rodríguez Palomo A, Mangas M, Cano JM, Buxo E, Álvarez-Manceñido F, García T, Lorenzo JE, Ferrer-Cardona M, Viudez A, Azkarate A, Ramchandani A, Arias D, Longo F, López C, Sánchez Bayona R, Limón ML, Díaz-Serrano A, Fernández Montes A, Sala P, Cerdá P, Rivera F, Gallego J. Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry. Gastric Cancer 2018; 21:96-105. [PMID: 28393278 DOI: 10.1007/s10120-017-0718-5] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/07/2017] [Accepted: 04/03/2017] [Indexed: 02/07/2023]
Abstract
BACKGROUND Although anthracycline-based triplets are one of the most widely used schedules to treat advanced gastric cancer (AGC), the benefit of including epirubicin in these therapeutic combinations remains unknown. This study aims to evaluate both the efficacy and tolerance of triplets with epirubicin vs. doublets with platinum-fluoropyrimidine in a national AGC registry. METHODS Patients with AGC treated with polychemotherapy without trastuzumab at 28 hospitals in Spain between 2008 and 2016 were included. The effect of anthracycline-based triplets against doublets was evaluated by propensity score matching (PSM) and Cox proportional hazards (PH) regression. RESULT A total of 1002 patients were included (doublets, n = 653; anthracycline-based triplets, n = 349). The multivariable Cox PH regression failed to detect significantly increased OS in favor of triplets with anthracyclines: HR 0.90 (95% CI, 0.78-1.05), p = 0.20035. After PSM, the sample contained 325 pairs with similar baseline characteristics. This method was also unable to reveal an increase in OS: 10.5 (95% CI, 9.7-12.3) vs. 9.9 (95% CI, 9.2-11.4) months, HR 0.91 (CI 95%, 0.76-1.083), and (log-rank test, p = 0.226). Response rates (42.1 vs. 33.1%, p = 0.12) and PFS (HR 0.95, CI 95%, 0.80-1.13, log-rank test, p = 0.873) were not significantly higher with epirubicin-based regimens. The triplets were associated with greater grade 3-4 hematological toxicity, and increased hospitalization due to toxicity by 68%. The addition of epirubicin is viable, but 23.7% discontinued treatment because of adverse effects or patient decision. CONCLUSION Anthracyclines added to platinum-fluoropyrimidine doublets did not improve the response rate or survival outcomes in patients with AGC but entailed greater toxicity.
Collapse
Affiliation(s)
- A Carmona-Bayonas
- Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, IMIB, Avenida Marqués de los Vélez, 30008, Murcia, Spain.
| | - P Jiménez-Fonseca
- Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain
| | - A Custodio
- Medical Oncology Department, Hospital Universitario La Paz, Madrid, Spain
| | - M Sánchez Cánovas
- Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, IMIB, Avenida Marqués de los Vélez, 30008, Murcia, Spain
| | - R Hernández
- Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain
| | - C Pericay
- Medical Oncology Department, Corporació Sanitària Parc Taulí , Sabadell, Spain
| | - I Echavarria
- Medical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain
| | - A Lacalle
- Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - L Visa
- Medical Oncology Department, Hospital Universitario Del Mar, Barcelona, Spain
| | - A Rodríguez Palomo
- Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain
| | - M Mangas
- Medical Oncology Department, Hospital Galdakao-Usansolo, Galdakao-Usansolo, Spain
| | - J M Cano
- Medical Oncology Department, Hospital General de Ciudad Real, Ciudad Real, Spain
| | - E Buxo
- Medical Oncology Department, Hospital Universitario Clinic, Barcelona, Spain
| | - F Álvarez-Manceñido
- Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain
| | - T García
- Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, IMIB, Avenida Marqués de los Vélez, 30008, Murcia, Spain
| | - J E Lorenzo
- Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain
| | - M Ferrer-Cardona
- Medical Oncology Department, Corporació Sanitària Parc Taulí , Sabadell, Spain
| | - A Viudez
- Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - A Azkarate
- Medical Oncology Department, Hospital Universitario Son Espases, Mallorca, Spain
| | - A Ramchandani
- Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain
| | - D Arias
- Medical Oncology Department, Complejo Hospitalario de Orense, Orense, Spain
| | - F Longo
- Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
| | - C López
- Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain
| | - R Sánchez Bayona
- Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain
| | - M L Limón
- Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain
| | - A Díaz-Serrano
- Medical Oncology Department, Hospital Universitario Doce de Octubre, Madrid, Spain
| | - A Fernández Montes
- Medical Oncology Department, Complejo Hospitalario de Orense, Orense, Spain
| | - P Sala
- Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain
| | - P Cerdá
- Medical Oncology Department, Clínica Tecknon de Barcelona, Barcelona, Spain
| | - F Rivera
- Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain
| | - J Gallego
- Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain
| | | |
Collapse
|
48
|
Gallego J, López C, Pazo-Cid R, López-Ríos F, Carrato A. Biomarkers in pancreatic ductal adenocarcinoma. Clin Transl Oncol 2017; 19:1430-1437. [PMID: 28616721 DOI: 10.1007/s12094-017-1691-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2017] [Accepted: 05/24/2017] [Indexed: 12/18/2022]
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is currently the third most frequent form of malignancy. The role of biomarkers in the diagnostic and therapeutic strategy of cancer is constantly expanding. Translational research is already changing paradigms in tumours encompassing from early diagnosis to precision medicine in advanced disease. Nomenclature for molecular subtypes of tumours is gradually gaining acceptance and there are growing expectations it will further go from the bench to the bedside. However, the clinical relevance of biomarkers in PDAC is still far behind the relevance of biomarkers in other solid tumours. This article is part of a wider project (GALLgo) involving over forty specialists devoted to the multidisciplinary management of PDAC which concluded in recommendations based on scientific evidence. The aim of the present article is to review the diagnostic, prognostic and predictive biomarkers, either in localised or advanced disease, which have been lately subjected to study and analysis and others currently available for PDAC in order to give strength-graded recommendations linked to quality of evidence that can be used as guidelines in routine clinical practice.
Collapse
Affiliation(s)
- J Gallego
- Department of Medical Oncology, University Hospital of Elche, Camí de l'Almazara, 11, Elche, 03203, Alicante, Spain.
| | - C López
- Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain
| | - R Pazo-Cid
- Department of Medical Oncology, Hospital Universitario Miguel Servet, Saragossa, Spain
| | - F López-Ríos
- Department of Pathology, Laboratorio de Dianas Terapéuticas, Hospital Universitario HM Sanchinarro, Madrid, Spain
| | - A Carrato
- Department of Medical Oncology, Madrid, Spain
| |
Collapse
|
49
|
Blanco Codesido M, Calvo Ferrandiz A, Lopez-Tarruella Cobo S, Alvarez R, Jerez Y, Marquez Rodas I, Perez Ramirez S, Muñoz A, Calles A, Sabin Domínguez P, López C, Picornell A, Puente B, Rubio C, Herencia M, Massarrah T, Jimenez MM. Validation of the Royal Marsden Hospital (RMH) prognostic score on an enriched early treatment line cohort for phase I trial patients. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx367.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
50
|
Pérez J, Llanos J, Sáez C, López C, Cañizares P, Rodrigo M. A microfluidic flow-through electrochemical reactor for wastewater treatment: A proof-of-concept. Electrochem commun 2017. [DOI: 10.1016/j.elecom.2017.07.026] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|